Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Sleep Disorders

  Free Subscription

Articles published in J Neurol

Retrieve available abstracts of 56 articles:
HTML format

Single Articles

    April 2024
  1. MCWILLIAM O, Gramkow MH, Blaabjerg M, Clemmensen FK, et al
    Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
    J Neurol. 2024;271:1707-1716.
    PubMed     Abstract available

  2. WANG R, Lian T, He M, Guo P, et al
    Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease.
    J Neurol. 2024;271:1959-1972.
    PubMed     Abstract available

  3. TAHA HB, Bogoniewski A
    Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.
    J Neurol. 2024;271:1680-1706.
    PubMed     Abstract available

  4. PALAGINI L, Manni R, Liguori C, De Gennaro L, et al
    Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group.
    J Neurol. 2024;271:1668-1679.
    PubMed     Abstract available

    March 2024
  5. FEIGL B, Lewis SJG, Rawashdeh O
    Targeting sleep and the circadian system as a novel treatment strategy for Parkinson's disease.
    J Neurol. 2024;271:1483-1491.
    PubMed     Abstract available

    January 2024
  6. JENSEN S, Abeler K, Friborg O, Rosner A, et al
    Insomnia and sleep-disordered breathing in FKRP-related limb-girdle muscular dystrophy R9. The Norwegian LGMDR9 cohort study (2020).
    J Neurol. 2024;271:274-288.
    PubMed     Abstract available

    December 2023
  7. SHIRAISHI T, Yoshimaru D, Umehara T, Ozawa M, et al
    Interactive effect of orthostatic hypotension on gray matter atrophy associated with hyposmia and RBD in de novo Parkinson's disease.
    J Neurol. 2023;270:5924-5934.
    PubMed     Abstract available

    November 2023
  8. BELLOFATTO M, Gentile L, Bertini A, Tramacere I, et al
    Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease.
    J Neurol. 2023;270:5561-5568.
    PubMed     Abstract available

    October 2023
  9. LIU EN, Yang JH, Patel L, Arora J, et al
    Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.
    J Neurol. 2023;270:4661-4672.
    PubMed     Abstract available

    September 2023
  10. PARK DG, Kim JY, Kim MS, Kim MH, et al
    Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.
    J Neurol. 2023;270:4393-4402.
    PubMed     Abstract available

    June 2023
  11. COLLIA A, Iranzo A, Serradell M, Munoz-Lopetegi A, et al
    Former participation in professional football as an occupation in patients with isolated REM sleep behavior disorder leading to a synucleinopathy: a case-control study.
    J Neurol. 2023;270:3234-3242.
    PubMed     Abstract available

  12. CICERO CE, Luca A, Mostile G, Donzuso G, et al
    Influence of RBD onset on the clinical characteristics of Parkinson's disease patients: a retrospective study.
    J Neurol. 2023;270:3171-3178.
    PubMed     Abstract available

  13. CANNIZZARO M, Pieri V, Curti DG, Gueye M, et al
    Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report.
    J Neurol. 2023;270:3246-3251.

    April 2023
  14. GADOTH A, Devine MF, Pittock SJ, McKeon A, et al
    Sleep disturbances associated with DPPX autoantibodies: a case series.
    J Neurol. 2023 Apr 7. doi: 10.1007/s00415-023-11698.
    PubMed     Abstract available

  15. WANG J, Tian Y, Qin C, Meng L, et al
    Impaired glymphatic drainage underlying obstructive sleep apnea is associated with cognitive dysfunction.
    J Neurol. 2023;270:2204-2216.
    PubMed     Abstract available

    March 2023
  16. WANG S, Zheng X, Huang J, Lin J, et al
    Restless legs syndrome and cognitive function among adults: a systematic review and meta-analysis.
    J Neurol. 2023;270:1361-1370.
    PubMed     Abstract available

    February 2023
  17. HENGEL H, Martus P, Faber J, Giunit P, et al
    The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors.
    J Neurol. 2023;270:944-952.
    PubMed     Abstract available

    December 2022
  18. HAWKEN J, Robertson N
    Sleep disorders in Parkinson's disease.
    J Neurol. 2022;269:6685-6687.

    October 2022
  19. FERNANDES M, Mari L, Chiaravalloti A, Paoli B, et al
    (18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.
    J Neurol. 2022;269:5356-5367.
    PubMed     Abstract available

    September 2022
  20. BRAMICH S, King A, Kuruvilla M, Naismith SL, et al
    Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies.
    J Neurol. 2022;269:4684-4695.
    PubMed     Abstract available

  21. CHU M, Xie K, Zhang J, Chen Z, et al
    Proposal of new diagnostic criteria for fatal familial insomnia.
    J Neurol. 2022;269:4909-4919.
    PubMed     Abstract available

  22. NABIZADEH F, Pirahesh K, Valizadeh P
    REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.
    J Neurol. 2022;269:4836-4845.
    PubMed     Abstract available

    May 2022
  23. SPARASCI D, Gobbi C, Castelnovo A, Riccitelli GC, et al
    Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping.
    J Neurol. 2022 May 4. pii: 10.1007/s00415-022-11143.
    PubMed     Abstract available

  24. WANG XT, Yu H, Liu FT, Zhang C, et al
    Associations of sleep disorders with cerebrospinal fluid alpha-synuclein in prodromal and early Parkinson's disease.
    J Neurol. 2022;269:2469-2478.
    PubMed     Abstract available

  25. ADAM O, Azher S, Valachovic E, Hahn A, et al
    Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents.
    J Neurol. 2022;269:2430-2439.
    PubMed     Abstract available

    April 2022
  26. YIANGOU A, Mitchell JL, Nicholls M, Chong YJ, et al
    Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT).
    J Neurol. 2022;269:1945-1956.
    PubMed     Abstract available

    March 2022
  27. OLTRA J, Segura B, Uribe C, Monte-Rubio GC, et al
    Sex differences in brain atrophy and cognitive impairment in Parkinson's disease patients with and without probable rapid eye movement sleep behavior disorder.
    J Neurol. 2022;269:1591-1599.
    PubMed     Abstract available

  28. MONTANARO E, Romagnolo A, Fabbri M, Artusi CA, et al
    Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson's disease.
    J Neurol. 2022;269:1538-1545.
    PubMed     Abstract available

    February 2022
  29. KOCH J, Willemsen K, Dogan I, Rolke R, et al
    Quantitative sensory testing and norepinephrine levels in REM sleep behaviour disorder - a clue to early peripheral autonomic and sensory dysfunction?
    J Neurol. 2022;269:923-932.
    PubMed     Abstract available

    January 2022
  30. FATEMEH G, Sajjad M, Niloufar R, Neda S, et al
    Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2022;269:205-216.
    PubMed     Abstract available

  31. GILAT M, Marshall NS, Testelmans D, Buyse B, et al
    A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials.
    J Neurol. 2022;269:125-148.
    PubMed     Abstract available

    November 2021
  32. ZHANG G, Zhang L, Xia K, Zhuang Z, et al
    Daytime sleepiness might increase the risk of ALS: a 2-sample Mendelian randomization study.
    J Neurol. 2021;268:4332-4339.
    PubMed     Abstract available

    October 2021
  33. TITOVA OE, Yuan S, Baron JA, Lindberg E, et al
    Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis.
    J Neurol. 2021 Oct 1. pii: 10.1007/s00415-021-10824.
    PubMed     Abstract available

    September 2021
  34. CORDANI R, Veneruso M, Napoli F, Milanaccio C, et al
    Sleep disturbances in craniopharyngioma: a challenging diagnosis.
    J Neurol. 2021 Sep 14. pii: 10.1007/s00415-021-10794.
    PubMed     Abstract available

  35. MARQUES A, Roquet D, Matar E, Taylor NL, et al
    Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.
    J Neurol. 2021;268:3371-3380.
    PubMed     Abstract available

    August 2021
  36. GUO Y, Liu FT, Hou XH, Li JQ, et al
    Predictors of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies.
    J Neurol. 2021;268:2713-2722.
    PubMed     Abstract available

    July 2021
  37. FIELDS T, Schoser B, Oertel W, Strupp M, et al
    Acetyl-DL-leucine improves restless legs syndrome: a case report.
    J Neurol. 2021;268:2595-2596.

  38. SCHAEFFER E, Vaterrodt T, Zaunbrecher L, Liepelt-Scarfone I, et al
    Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
    J Neurol. 2021;268:2506-2514.
    PubMed     Abstract available

    June 2021
  39. SIMONET C, Schrag A, Lees AJ, Noyce AJ, et al
    The motor prodromes of parkinson's disease: from bedside observation to large-scale application.
    J Neurol. 2021;268:2099-2108.
    PubMed     Abstract available

    April 2021
  40. JIMENEZ-JIMENEZ FJ, Amo G, Alonso-Navarro H, Calleja M, et al
    Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome.
    J Neurol. 2021;268:1461-1472.
    PubMed     Abstract available

  41. SUZUKI K, Suzuki S, Haruyama Y, Okamura M, et al
    Central sensitization in migraine is related to restless legs syndrome.
    J Neurol. 2021;268:1395-1401.
    PubMed     Abstract available

    March 2021
  42. IRANZO A, Marrero-Gonzalez P, Serradell M, Gaig C, et al
    Significance of hyposmia in isolated REM sleep behavior disorder.
    J Neurol. 2021;268:963-966.
    PubMed     Abstract available

    February 2021
  43. CHEN CY, Chen CL, Yu CC
    Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study.
    J Neurol. 2021 Feb 24. pii: 10.1007/s00415-021-10480.
    PubMed     Abstract available

    January 2021
  44. MARELLI S, Castelnuovo A, Somma A, Castronovo V, et al
    Impact of COVID-19 lockdown on sleep quality in university students and administration staff.
    J Neurol. 2021;268:8-15.
    PubMed     Abstract available

  45. XU Z, Anderson KN, Saffari SE, Lawson RA, et al
    Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study.
    J Neurol. 2021;268:312-320.
    PubMed     Abstract available

  46. ANDELIC N, Roe C, Brunborg C, Zeldovich M, et al
    Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study.
    J Neurol. 2021;268:61-73.
    PubMed     Abstract available

    June 2020
  47. DAFSARI HS, Ray-Chaudhuri K, Ashkan K, Sachse L, et al
    Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    J Neurol. 2020;267:1830-1841.
    PubMed     Abstract available

    May 2020
  48. HATTORI M, Tsuboi T, Yokoi K, Tanaka Y, et al
    Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study.
    J Neurol. 2020;267:1516-1526.
    PubMed     Abstract available

    April 2020
  49. ELFIL M, Ahmed N, Alapati A, Bahekar R, et al
    Suicidal risk and demoralization in Parkinson disease.
    J Neurol. 2020;267:966-974.
    PubMed     Abstract available

    February 2020
  50. RATTAY TW, Boldt A, Volker M, Wiethoff S, et al
    Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).
    J Neurol. 2020;267:369-379.
    PubMed     Abstract available

  51. MASSEY TH, Robertson NP
    Restless legs syndrome: causes and consequences.
    J Neurol. 2020;267:575-577.

  52. LABERGE L, Gallais B, Auclair J, Dauvilliers Y, et al
    Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
    J Neurol. 2020;267:461-468.
    PubMed     Abstract available

  53. MATAR E, Ehgoetz Martens KA, Halliday GM, Lewis SJG, et al
    Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology.
    J Neurol. 2020;267:380-389.
    PubMed     Abstract available

  54. LU HT, Shen QY, Zhao QZ, Huang HY, et al
    Association between REM sleep behavior disorder and impulsive-compulsive behaviors in Parkinson's disease: a systematic review and meta-analysis of observational studies.
    J Neurol. 2020;267:331-340.
    PubMed     Abstract available

    January 2020
  55. KEIR LHM, Breen DP
    New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease.
    J Neurol. 2020;267:288-294.
    PubMed     Abstract available

    December 2019
  56. GAETA AM, Benitez ID, Jorge C, Torres G, et al
    Prevalence of obstructive sleep apnea in Alzheimer's disease patients.
    J Neurol. 2019 Dec 12. pii: 10.1007/s00415-019-09668.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge.